AIM Company Profile and Key Details

Q: Who are the executives of AIM?

Dr. Carol A. SmithChief Manufacturing Officer & Deputy Chief Scientific OfficerDr. Christopher McAleer Ph.D.Scientific OfficerDr. David R. Strayer M.D.Chief Scientific Officer & Medical DirectorAnn Marie E. CoverlyDirector of Admin. & HR and Deputy Investor Relations CoordinatorJodie PelzControllerDr. Ralph Christopher Cavalli Ph.D.Vice President of QC & ManufacturingMr. Thomas K. Equels Esq., J.D., M.S.Executive Vice Chairman, Chief Executive Officer & PresMr. Peter W. Rodino III, Esq., J.D.Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

AMEX : AIM

AIM ImmunoTech

$0.39

0.161+69.19%

Open: 2:33 PM

63.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

AIM ImmunoTech Inc. (AIM) stock surged +69.19%, trading at $0.39 on AMEX, up from the previous close of $0.23. The stock opened at $0.25, fluctuating between $0.24 and $0.60 in the recent session.

Stock Snapshot

0.2327

Prev. Close

1.34M

Market Cap

0.24

Day Low

-0.09

P/E Ratio

-4.31

EPS (TTM)

-0.45

Cash Flow per Share

0.25

Open

3.4M

Number of Shares

0.5998

Day High

95.49%

Free Float in %

0.21

Book Value

471.07M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 26, 2026	0.23	0.24	0.23	0.23	5.57M
May 22, 2026	0.25	0.25	0.23	0.24	3.68M
May 21, 2026	0.26	0.26	0.23	0.24	6.62M
May 20, 2026	0.37	0.46	0.21	0.25	12.53M
May 19, 2026	0.37	0.43	0.33	0.41	12.89M
May 18, 2026	0.28	0.69	0.27	0.41	470.03M
May 15, 2026	0.26	0.26	0.24	0.25	717.06K
May 14, 2026	0.27	0.29	0.25	0.26	1.02M
May 13, 2026	0.30	0.30	0.27	0.27	698.53K
May 12, 2026	0.31	0.31	0.27	0.29	730.37K
May 11, 2026	0.34	0.34	0.29	0.31	1.43M
May 08, 2026	0.36	0.38	0.33	0.34	3.22M
May 07, 2026	0.52	0.69	0.46	0.56	8.5M
May 06, 2026	0.51	0.51	0.48	0.48	170.71K
May 05, 2026	0.52	0.52	0.51	0.52	46.46K
May 04, 2026	0.51	0.53	0.50	0.52	109.1K
Apr 30, 2026	0.52	0.53	0.51	0.52	119.25K
Apr 29, 2026	0.52	0.53	0.51	0.52	64.83K
Apr 28, 2026	0.52	0.54	0.51	0.52	127.37K
Apr 27, 2026	0.53	0.54	0.50	0.52	237.32K

Contact Details

Ocala, FL 34473

United States

https://aimimmuno.com 352 448 7797

About Company

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Stock Peers

TBXU

0.0621+0.21%

Direxion Daily Biotech Top 5 Bull 2X ETF$29.04 PTHS

0.51+1.91%

Pelthos Therapeutics Inc.$27.17 PTN

-0.2263-1.52%

Palatin Technologies, Inc.$14.65 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 ARMP

-0.19-2.27%

Armata Pharmaceuticals, Inc.$8.17 NRXS

-0.38-5.15%

NeurAxis, Inc.$7.00 CANF

0.04+1.18%

Can-Fite BioPharma Ltd.$3.44 NSRX

-0.07-2.41%

Nasus Pharma Ltd.$2.83 PLX

0.04+1.90%

Protalix BioTherapeutics, Inc.$2.14

Frequently Asked Questions

What is the current AIM ImmunoTech Inc. (AIM) stock price?

AIM ImmunoTech Inc. (AMEX: AIM) stock price is $0.39 in the last trading session. During the trading session, AIM stock reached the peak price of $0.60 while $0.24 was the lowest point it dropped to. The percentage change in AIM stock occurred in the recent session was 69.19% while the dollar amount for the price change in AIM stock was $0.16.

AIM's industry and sector of operation?

The AMEX listed AIM is part of Biotechnology industry that operates in the broader Healthcare sector. AIM ImmunoTech Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AIM?

Dr. Carol A. Smith
Chief Manufacturing Officer & Deputy Chief Scientific Officer
Dr. Christopher McAleer Ph.D.
Scientific Officer
Dr. David R. Strayer M.D.
Chief Scientific Officer & Medical Director
Ann Marie E. Coverly
Director of Admin. & HR and Deputy Investor Relations Coordinator
Jodie Pelz
Controller
Dr. Ralph Christopher Cavalli Ph.D.
Vice President of QC & Manufacturing
Mr. Thomas K. Equels Esq., J.D., M.S.
Executive Vice Chairman, Chief Executive Officer & Pres
Mr. Peter W. Rodino III, Esq., J.D.
Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

How AIM did perform over past 52-week?

AIM's closing price is 10.81% higher than its 52-week low of $0.21 where as its distance from 52-week high of $19.74 is -98.82%.

How many employees does AIM have?

Number of AIM employees currently stands at 21.

Link for AIM official website?

Official Website of AIM is: https://aimimmuno.com

How do I contact AIM?

AIM could be contacted at phone 352 448 7797 and can also be accessed through its website. AIM operates from 2117 SW Highway 484, Ocala, FL 34473, United States.

How many shares of AIM are traded daily?

AIM stock volume for the day was 471.07M shares. The average number of AIM shares traded daily for last 3 months was 12.27M.

What is the market cap of AIM currently?

The market value of AIM currently stands at $1.34M with its latest stock price at $0.39 and 3.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	21
Beta	1.36
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	21
Beta	1.36
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AIM Company Profile and Key Details

AIM ImmunoTech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways